Lie-A-Ling M, Bakker CT, Deurholt T, et al. Selection of tumour specific promoters for adenoviral gene therapy of cholangiocarcinoma[J]. J Hepatol, 2006, 44（1）：126-133.
[2]
Fang L, Shanqu L, Ping G, et al. Gene therapy with RNAi targeting UHRF1 driven by tumor-specific promoter inhibits tumor growth and enhances the sensitivity of chemotherapeutic drug in breast cancer in vitro and in vivo[J]. Cancer Chemother Pharmacol, 2012, 69（4）：1079-1087.
[3]
Wolfe AL, Singh K, Zhong Y, et al. RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer[J]. Nature, 2014, 513（7516）：65-70.
[4]
DeFatta RJ, Li Y, De Benedetti A. Selective killing of cancer cells based on translational control of a suicide gene[J]. Cancer Gene Ther, 2002, 9（7）：573-578.
[5]
Cipollini M, Landi S, Gemignani F. MicroRNA binding site polymorphisms as biomarkers in cancer management and research[J]. Pharmgenomics Pers Med, 2014, 7：173-1791.
[6]
Mazzacurati L, Marzulli M, Reinhart B, et al. Use of miRNA response sequences to block off-target replication and increase the safety of an unattenuated, glioblastoma-targeted oncolytic HSV[J]. Mol Ther, 2015, 23（1）：99-107.
[7]
Lai YH, Lin CC, Chen SH, et al. Tumor-specific suicide gene therapy for hepatocellular carcinoma by transcriptionally targeted retroviral replicating vectors[J]. Gene Ther, 2015, 22（2）：155-162.
[8]
Kogo R, How C, Chaudary N, et al. The microRNA-218~Survivin axis regulates migration, invasion, and lymph node metastasis in cervical cancer[J]. Oncotarget, 2015, 6（2）：1090-1100.
[9]
Hynes NE, Stoelzle T. Key signalling nodes in mammary gland development and cancer：Myc[J]. Breast Cancer Res, 2009, 11（5）：210.
[10]
Lang KJ, Kappel A, Goodall GJ. Hypoxia-inducible factor-1alpha mRNA contains an internal ribosome entry site that allows efficient translation during normoxia and hypoxia[J]. Mol Biol Cell, 2002, 13（5）：1792-1801.
[11]
Fang Y, Xue JL, Shen Q, et al. MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma[J]. Hepatology, 2012, 55（6）：1852-1862.
[12]
Spilka R, Ernst C, Mehta AK, et al. Eukaryotic translation initiation factors in cancer development and progression[J]. Cancer Lett, 2013, 340（1）：9-21.
[13]
Moussavi M, Moshgabadi N, Fazli L, et al. Fibroblast growth factor and ornithine decarboxylase 5''UTRs enable preferential expression in human prostate cancer cells and in prostate tumors of PTEN（-/-）transgenic mice[J]. Cancer Gene Ther, 2012, 19（1）：19-29.
[14]
Valinezhad Orang A, Safaralizadeh R, Kazemzadeh-Bavili M. Mechanisms of miRNA-mediated gene regulation from common downregulation to mRNA-specific upregulation[J]. Int J Genomics, 2014：970607.
[15]
Li JM, Kao KC, Li LF, et al. MicroRNA-145 regulates oncolytic herpes simplex virus-1 for selective killing of human non-small cell lung cancer cells[J]. Virol J, 2013, 10：241.
[16]
Habibie, Yokoyama S, Abdelhamed S, et al. Survivin suppression through STAT3/β-catenin is essential for resveratrol-induced melanoma apoptosis[J]. Int J Oncol, 2014, 45（2）：895-901.
[17]
Paik S, Shak S, Tang G, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer[J]. N Engl J Med, 2004, 351（27）：2817-2826.
[18]
Meijer TW, Kaanders JH, Span PN, et al. Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy[J]. Clin Cancer Res, 2012, 18（20）：5585-5594.
[19]
Shi Y, Frost P, Hoang B, et al. MNK kinases facilitate c-myc IRES activity in rapamycin -treated multiple myeloma cells[J]. Oncogene, 2013, 32（2）：190-197.
[20]
Sujobert P, Bardet V, Cornillet-Lefebvre P, et al. Essential role for the p110delta isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia[J]. Blood, 2005, 106（3）：1063-1066.
[21]
Foka P, Pourchet A, Hernandez AR, et al. Novel tumour-specific promoters for？transcriptional？targeting？of hepatocellular carcinoma by herpes simplex virus vectors[J]. J Gene Med, 2010, 12（12）：956-967.
[22]
Lukowski SW, Rothnagel JA, Trezise AE. CFTR mRNA expression is regulated by an upstream open reading frame and RNA secondary structure in its 5'' untranslated region[J]. Hum Mol Genet, 2015, 24（4）：899-912.
